Latest news on Bispecific Antibodies market Research Report by 2035
Given the recent approval of a number of bispecific antibodies and several ongoing R&D efforts focused on evaluating the potential of such candidates against various disease indications, this sector of the pharmaceutic industry has garnered significant interest of stakeholder The USD 16.8 billion (by 2035) financial opportunity within bispecific antibodies market has been analyzed across the following segments: § Therapeutic Area § Autoimmune Disorders § Genetic Disorders § Hematological Malignancies § Ophthalmic Disorders § Skin Cancers § Solid Tumors § Mechanism of Action § Cytokines Retargeting / Neutralization § Dual Ligands Blocking § Resistance Factors Co-targeting § Targeting Tumor Angiogenesis § T-Cell Retargeting / Activation § Others § Target Antigen § C5-Albumin § CD20 x CD3 § CD3 x BCMA § CD3 x CD19 § EGFR x cMET § EpCAM x CD3 § Factor IXa x Factor X § gp100 x CD3 § HER2 x HER2 § PD-1 x CTLA-4 § PD-L1 x TGFβ § TNF-α x HSA § VEGF x DLL4 § VEGF-A x ANG2 § Antibody Format § Asymmetric § Fragments § Key Players § Akeso Biopharma § Alexion § Amgen § Genmab § Immunocore § Janssen Research & Development § Linton Pharm § Merck § OncXerna Therapeutics § Pfizer § Roche § Taisho Pharmaceutical § Zymeworks § Key Geographical Regions § Asia § Europe § North America § Rest of the World The Bispecific Antibodies Market, 2023-2035, report features the following companies, which we identified to be key players in this domain: § Akeso Biopharma § Alphamab Oncology § Amgen § Merck § Regeneron § Roche § Xencor Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape of Approved and Clinical Therapies 5. Market Landscape of Preclinical Therapies 6. Key Insights 7. Technology Assessment Framework 8. Big Pharma Players: Benchmarking Analysis 9. Company Profiles 10. Partnerships and Collaborations 11. Contract Services for Bispecific Antibody Therapeutics 12. Clinical Trial Analysis 13. Case Study: Regulatory Guidelines for Bispecific Antibodies 14. Case Study: Promotional / Marketing Strategies 15. Market Forecast and Opportunity Analysis 16. SWOT Analysis 17. Concluding Remarks 18. Executive insights 19. Appendix 1: Tabulated data 20. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html Learn from experts: do you know about these emerging industry trends? Top 9 Antibody Discovery Companies offering Antibody Discovery Platforms Top 5 Lipid Nanoparticles Manufacturer Providing LNP Manufacturing Contract Services About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Contact: Ben Johnson
| S | M | T | W | T | F | S |
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |